BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+57.51%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$3.59B
AUM Growth
+$3.59B
(+31%)
Cap. Flow
-$161M
Cap. Flow
% of AUM
-4.48%
Top 10 Holdings %
Top 10 Hldgs %
60.96%
Holding
76
New
4
Increased
8
Reduced
4
Closed
9
Top Buys
| 1 |
IDEAYA Biosciences
IDYA
|
$75.9M |
| 2 |
Revolution Medicines
RVMD
|
$34.8M |
| 3 |
Janux Therapeutics
JANX
|
$29.9M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$11.7M |
| 5 |
ALLK
Allakos
ALLK
|
$11.3M |
Top Sells
| 1 |
Syndax Pharmaceuticals
SNDX
|
$45.3M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$44M |
| 3 |
Immunovant
IMVT
|
$39.7M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$37M |
| 5 |
Merus
MRUS
|
$36.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Crinetics Pharmaceuticals
CRNX
$3.26B
| – | – |
-2,736,613
| Closed | -$44M |
|